48 results on '"Kochar, Bharati"'
Search Results
2. Inflammation and aging-related disease: A transdisciplinary inflammaging framework
3. Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases
4. Comorbidity Influences the Comparative Safety of Biologic Therapy in Older Adults With Inflammatory Bowel Diseases.
5. Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study.
6. Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases
7. Very Early Pouchitis Is Associated with an Increased Likelihood of Chronic Inflammatory Conditions of the Pouch
8. The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults With Inflammatory Bowel Diseases and Cirrhosis
9. Underrepresentation of Racial and Ethnic Minorities in High-Impact Cirrhosis Clinical Trials
10. Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study
11. Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data
12. Incidence, severity, and mortality of post-ERCP pancreatitis: an updated systematic review and meta-analysis of 145 randomized controlled trials
13. Relationship Between Stages of Ileal Pouch-Anal Anastomosis, Timing of Restoration of Fecal Continuity, and Pouchitis
14. Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases
15. The landscape of immune dysregulation in Crohn’s disease revealed through single-cell transcriptomic profiling in the ileum and colon
16. Sarcopenia in Inflammatory Bowel Diseases: Reviewing Past Work to Pave the Path for the Future
17. Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor α Antagonists in Inflammatory Bowel Diseases
18. Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study
19. Managing the older adult with inflammatory bowel disease: is age just a number?
20. The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals
21. Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults
22. Yield and Predictors of Surveillance Colonoscopies in Older Adults With Long-standing Ulcerative Colitis
23. Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty
24. Pharmacoequity in Older Patients With Inflammatory Bowel Disease.
25. Pharmacoequity for Older Adults With Inflammatory Bowel Diseases
26. Vaping-associated esophagitis
27. Differences in Management and Outcomes of Older and Younger Adults with Acute Severe Ulcerative Colitis.
28. Oral vs Intravenous Discharge Antibiotic Regimens in the Management of Intra-abdominal Abscesses in Penetrating Crohn’s Disease
29. Differences in Management and Outcomes of Older and Younger Adults with Acute Severe Ulcerative Colitis
30. The Discrepant Visual Representation of Inflammatory Bowel Diseases in the Internet and Media
31. Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.
32. Optimal Dysplasia Detection and Management in IBD: Now and in the Future.
33. Underrepresentation of Racial and Ethnic Minorities in High-Impact Cirrhosis Clinical Trials
34. A Narrative Review of Financial Burden, Distress, and Toxicity of Inflammatory Bowel Diseases in the United States.
35. Current Perspectives on Indications for Ileal Pouch-Anal Anastomosis in Older Patients
36. Tu1435: TOFACITINIB IS NOT ASSOCIATED WITH A HIGHER RISK OF THROMBOTIC AND CARDIOVASCULAR EVENTS COMPARED WITH ANTITUMOR NECROSIS FACTORS AGENTS IN PATIENTS WITH IBD
37. Mo1548: RISK OF INFECTIONS WITH USTEKINUMAB AND TOFACITINIB COMPARED TO TUMOR NECROSIS FACTOR ANTANOGISTS IN INFLAMMATORY BOWEL DISEASES
38. 580: ASSOCIATION OF PROTON PUMP INHIBITOR USE AND COGNITIVE DECLINE AND INCIDENT DEMENTIA IN OLDER ADULTS
39. 455: COMORBIDITY INFLUENCES THE COMPARATIVE SAFETY OF BIOLOGIC THERAPY IN OLDER ADULTS WITH INFLAMMATORY BOWEL DISEASES
40. Association of midlife antibiotic use with subsequent cognitive function in women
41. The Association between Polypharmacy, Frailty and Disability-Free Survival in Community-Dwelling Healthy Older Individuals
42. Tu1807 PRIOR TREATMENT WITH TOFACITINIB DOES NOT AFFECT INITIAL RESPONSE TO UPADACITINIB IN ULCERATIVE COLITIS
43. Patients With Inflammatory Bowel Diseases Are at Higher Risk for Meningitis
44. Inflammatory bowel diseases.
45. Frailty integration in medical specialties: Current evidence and suggested strategies from the Clin‐STAR frailty interest group.
46. Older Adults with Celiac Disease Are At Increased Risk of Frailty:A Nationwide Cohort Study.
47. A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease.
48. IBD Is Like a Tree: Reflections From Older Adults With Inflammatory Bowel Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.